Human Papillomavirus in HNSCC: A European Epidemiologic Perspective

Hematology/Oncology Clinics of North America

Volumn 22, Issue 6, 2008, Pages 1143-1153

  Licitra, Lisa ^a,c   Zigon, Giulia ^a,c   Gatta, Gemma ^a,c   Sánchez, Maria José ^b,c   Berrino, Franco ^a,c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c Austrian National Cancer Registry   (Germany)

Author keywords

European incidence trends; Head and neck cancer; Human papillomavirus; Survival trends

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER INCIDENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; EUROPE; HEAD AND NECK NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SURVIVAL RATE;

EID: 56049120626     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.10.002     Document Type: Review

References (24)

1. Ferlay J., Bray F., Pisani P., et al. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0 (2004), IARCPress, Lyon (France)
2. Gilison M.L. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31 6 (2004) 744-754
3. Kreimer A.R., Clifford G.M., Boyle P., et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 2 (2005) 467-475
4. Ernster J.A., Sciotto C.G., O'Brien M.M., et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 117 12 (2007) 2115-2128
5. Carvalho A.L., Nishimoto I.N., Califano J.A., et al. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114 5 (2005) 806-816
6. Shiboski C.H., Schmidt B.L., and Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the US population ages 20-44 years. Cancer 103 9 (2005) 1843-1849
7. Hammarstedt L., Lindquist D., Dahlstrand H., et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119 11 (2006) 2620-2623
8. Chaturvedi A.K., Engels E.A., Anderson W.F., et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26 4 (2008) 612-619
9. In: Fritz A., Percy C., Jack A., et al. (Eds). International classification of diseases for oncology. 3rd edition (2000), World Health Organization, Geneva (Switzerland)
10. JRP. Joinpoint Regression Program, Release 3.3.1 (2008), Statistical research and applications branch, National Cancer Institute. http://srab.cancer.gov/joinpoint/ Accessed April 2008
11. SEER*Stat Release 6.4.4 S. Available at:. http://seer.cancer.gov/seerstat/ Accessed April 24, 2008
12. Ederer F., Axtell L.M., and Cutler S.J. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6 (1961) 101-121
13. Henson D.E., and Ries L.A. The relative survival rate. Cancer 76 10 (1995) 1687-1688
14. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38 4 (1982) 933-942
15. Corazziari I., Quinn M., and Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40 15 (2004) 2307-2316
16. Karim-Kos H.E., de V.E., Soerjomataram I., et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 10 (2008) 1345-1389
17. Lehtinen M., and Paavonen J. Effectiveness of preventive human papillomavirus vaccination. Int J STD AIDS 14 12 (2003) 787-792
18. Applebaum K.M., Furniss C.S., Zeka A., et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 99 23 (2007) 1801-1810
19. Berrino F., De A.R., Sant M., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 9 (2007) 773-783
20. Coleman M.P., Gatta G., Verdecchia A., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14 Suppl 5 (2003) v128-v149
21. Kumar B., Cordell K.G., Lee J.S., et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26 19 (2008) 3128-3137
22. Friesland S., Mellin H., Munck-Wikland E., et al. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma: relation to radiotherapy response and survival. Anticancer Res 21 1B (2001) 529-534
23. Lindel K., Beer K.T., Laissue J., et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92 4 (2001) 805-813
24. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356 19 (2007) 1944-1956